P708: Helicobacter pylori and IBD are inversely related, suggesting that individuals infected with the bacteria are less susceptible to the diseaseECCO '17 Barcelona
2017
P709: inflammatory bowel disease and colorectal cancer: analysis of a single center retrospective chart reviewECCO '17 Barcelona
2017
P711: Vegetarian or gluten-free diet in patients with IBD – associated with lower psychological well-being and quality of life but no indication of beneficial effects on course of diseaseECCO '17 Barcelona
2017
P712: Risk factors for the development of fistulae and stenoses in Crohn's disease patients in the Swiss IBD cohortECCO '17 Barcelona
2017
P713: Possible explanations of the marked differences in the incidence of microscopic colitis between Denmark and SwedenECCO '17 Barcelona
2017
P714: Vitamin D deficiency in inflammatory bowel disease: prevalence and relation to disease activity in a cohort of patients of a Mediterranean countryECCO '17 Barcelona
2017
P715: Trends in emergency department visits and hospitalization rates for inflammatory bowel disease: results from a single-center in 2004, 2009 and 2014ECCO '17 Barcelona
2017
P716: Beta-blocker use is associated with a higher relapse risk of inflammatory bowel disease – a Dutch retrospective cohort studyECCO '17 Barcelona
2017
P717: Higher ulcerative colitis/Crohn's disease ratio in a central region of ArgentinaECCO '17 Barcelona
2017
P718: The epidemiology of IBD differs in South Asian migrants compared to Caucasians; results from a systematic review and meta-analysisECCO '17 Barcelona
2017
P720: Use of proton pump inhibitors associated with a markedly increased risk of microscopic colitisECCO '17 Barcelona
2017
P721: A switch in the prevalence ratio of Crohn's disease vs. ulcerative colitis in Israel between 2003 and 2015 – a report from the epi-IIRN groupECCO '17 Barcelona
2017
P722: Prediagnostic serum vitamin D levels and risk of inflammatory bowel disease: a pan-European, nested case-control studyECCO '17 Barcelona
2017
P725: The impact of an integrated model of care for patients with inflammatory bowel disease in CanadaECCO '17 Barcelona
2017